The flow cytometry market is expanding due to increased investment in immuno-oncology and liquid biopsy sectors. With advancements in genome-based research and single-cell analysis, flow cytometry ...
In recent years, antibodies have become an incredibly popular therapeutic target – with monoclonal antibodies (mAbs) becoming an ever more widely used therapy for a number of diseases, including ...
To schedule time for flow analysis, call 977-8877. Leave a message if you are unable to reach us immediately and we will return your call as soon as possible. Users are also welcome to stop by the ...
Flow cytometry is a high-throughput cell analysis method that utilizes monochromatic light and specifically angled detectors to infer the cell's size, granularity, and complexity based on the degree ...
Subjectivity in flow-cytometry data analysis has long been a challenge. Recent advancements in high-speed camera capabilities have led to the integration of morphological features with traditional ...
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, (NASDAQ: BIAF, BIAFW), a biotechnology company that develops noninvasive, early-stage diagnostics to detect cancer and diseases of the lung, ...
Investigators sought to show how individual cases could be clarified through the use of flow cytometry analysis. Corresponding author Theresia M. Westers, PhD, of Amsterdam University Medical Centers ...
Flow cytometry is widely used in areas of research that require analysis or isolation of cells from suspension. This technology makes use of fluorescent probes targeted to specific cell-associated ...
Flow cytometry remains a critical technology for the high-throughput analysis of single cells in complex populations. Attention to good practice for analysis is more important than ever due to the ...
FREMONT, Calif., March 18, 2025 (GLOBE NEWSWIRE) -- Today, Cytek Biosciences, Inc. (Nasdaq: CTKB) announced that it has added transformative capabilities to its iconic Cytek® Guava® Muse® cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results